Plasma brain natriuretic peptide concentrations and the risk of cardiovascular events and death in general practice

This publication has 28 references indexed in Scilit:

• The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT
  European Heart Journal, 2004
• Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
  Circulation, 2003
• High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
  JACC, 2000
• Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
  American Heart Journal, 1998
• Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
  Circulation, 1994
• Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
  Circulation, 1993
• Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide.
  Circulation Research, 1991
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
  Journal of Clinical Investigation, 1991
• Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.
  Journal of Clinical Investigation, 1989
• A new natriuretic peptide in porcine brain
  Nature, 1988